Medicine for Urinary Stones | Korean Products

May 21, 2019

Urocitra-K SR Tablet provides treatment of renal tubular acidosis (RTA) with calcium stones, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis with or without calcium stones. Through urine alkalization action with citraturic urine, it dissolves the calcium stones, uric acid stones and cystine stones, and inhibits their recurrence.
In combination with extracorporeal shock wave lithotripsy (ESWL), Urocitra-K features superior efficacy, particularly for patients undergoing ESWL and those with recurrent urinary stones.

A long-term administration of Urocitra-K improves tolerance and minimizes adverse effects.
Pharmbio Korea Inc. founded in 1999, is the first company to develop treatment for urinary stones in Korea, and has introduced Urocitra, an innovative product for urology, gastroenterology, general surgery, and ob-gyn, among others. Pharmbio Korea has been recognized as one of the most influential companies in the above-mentioned therapeutic areas, and was accredited by the by Korea’s Ministry of Knowledge and Economy in 2011 for its contributions to public health. | Blog Magazine of Korean products, brands and Goods

Other Products

New & Hot

Beauty Care

Gifts & Premiums

Medical & Health

Food & Beverage

Kitchen Utensils

Household Items

Tourist Attractions

Korean Home Appliance


More Products



More Chungbuk, Korea Products

Send Inquiry for "Medicine for Urinary Stones"
For More Information (Supplier, Price, Catalog, Detailed Information etc), please send an inquiry